Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?

In recent years, the studies on ovarian cancer have made great progress, but the morbidity and mortality of patients with ovarian cancer are still very high. Due to the lack of effective early screening and detecting tools, 70% of ovarian cancer patients are diagnosed at an advanced stage. The overa...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ming, Zhu, Yu, Teng, Lichen, Cui, Jialin, Su, Yajuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062166/
https://www.ncbi.nlm.nih.gov/pubmed/33936202
http://dx.doi.org/10.1155/2021/6627241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062166/
https://www.ncbi.nlm.nih.gov/pubmed/33936202
http://dx.doi.org/10.1155/2021/6627241

Ejemplares similares